NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02511106,"AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.",https://clinicaltrials.gov/study/NCT02511106,ADAURA,ACTIVE_NOT_RECRUITING,"To assess the efficacy and safety of AZD9291 versus Placebo, in patients with Epidermal Growth Factor Receptor Mutation Positive stage IB-IIIA non-small cell lung carcinoma, following complete tumour resection with or without adjuvant chemotherapy",YES,Stage IB-IIIA Non-small Cell Lung Carcinoma,DRUG: AZD9291 80 mg/40 mg|DRUG: Placebo AZD9291 80 mg/40 mg|DRUG: Open-label AZD9291 80 mg/40 mg,"Assess the Efficacy of AZD9291 Compared to Placebo as Measured by Disease Free Survival (DFS)., Defined as the time from the date of randomization until the date of disease recurrence or death (by any cause in the absence of recurrence)., Up to approximately 5 years after the first patient is randomized (maximum follow up of 70 months)","Disease Free Survival (DFS) Rate at 2, 3 and 5 Years, Defined as the percentage of patients alive and disease free at 2, 3 and 5 years, respectively, estimated from Kaplan Meier plots of the primary endpoint of DFS., Up to approximately 5 years after the first patient is randomized (maximum follow up of 70 months). DFS rate at 2 years (%), 3 years (%) and 5 years (%) are presented.|Overall Survival (OS), Defined as the time from the date of randomization until date of death due to any cause., Up to approximately 7 years after the first patient is randomized (maximum follow up of 86 months)|Overall Survival Rate at 2, 3 and 5 Years, Defined as the percentage of patients alive at 2, 3 and 5 years, respectively, estimated from a Kaplan Meier plot of OS., Up to approximately 7 years after the first patient is randomized (maximum follow up of 86 months). OS rate at 2 years (%), 3 years (%) and 5 years (%) are presented.|Patient Health-related Quality of Life and Symptoms (HRQoL) by SF-36v2 Health Survey., Change from baseline will be calculated for each domain and summary scale at each scheduled post-baseline assessment. The SF-36 includes eight domains: Physical Functioning (PF); Role Limitations-Physical (RP), Vitality (VT), General Health Perceptions (GH), Bodily Pain (BP), Social Function (SF), Role Limitations-Emotional (RE), and Mental Health (MH) and two summary scores: The Physical Component Summary (PCS) and Mental Component Summary (MCS). Final scores for each scale range from 0-100 with higher scores indicating better health., Measured by SF-36 Questionnaire at baseline, 12 week, 24 week and then every 24 weeks until study complete, disease recurrence or other discontinuation criteria met, up to 3 years.|Plasma Concentrations of AZD9291, The pharmacokinetics exposure parameters derived from plasma concentrations of AZD9291, Collected at pre-dose, 0.5-1.5hours and 2-4hours post-dose up to 96 weeks (approximately 24 months)|Plasma Concentrations of AZ5104 Metabolites, The pharmacokinetics exposure parameters derived from plasma concentrations of AZ5104 metabolites, From date of dosing to week 96 (approximately 24 months)|Plasma Concentrations of AZ7550 Metabolites, The pharmacokinetics exposure parameters derived from plasma concentrations of AZ7550 metabolites, From date of dosing to week 96 (approximately 24 months)",,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,682,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",D5164C00001|2023-506524-82-00|2015-000662-65,2015-10-21,2022-04-11,2029-01-31,2015-07-29,2021-07-27,2025-04-01,"Research Site, Los Angeles, California, 90048, United States|Research Site, Santa Monica, California, 90404, United States|Research Site, Santa Rosa, California, 95403, United States|Research Site, Torrance, California, 90505, United States|Research Site, Grand Junction, Colorado, 81501, United States|Research Site, New Haven, Connecticut, 06520, United States|Research Site, Norwalk, Connecticut, 06856, United States|Research Site, Fort Myers, Florida, 33901, United States|Research Site, Pembroke Pines, Florida, 33028, United States|Research Site, Saint Petersburg, Florida, 33705, United States|Research Site, Athens, Georgia, 30607, United States|Research Site, Honolulu, Hawaii, 96819, United States|Research Site, Chicago, Illinois, 60612, United States|Research Site, Elk Grove Village, Illinois, 60007, United States|Research Site, Bethesda, Maryland, 20817, United States|Research Site, Brick, New Jersey, 08724, United States|Research Site, Florham Park, New Jersey, 07932, United States|Research Site, Mineola, New York, 11501, United States|Research Site, Pawtucket, Rhode Island, 02860, United States|Research Site, Chattanooga, Tennessee, 37404, United States|Research Site, Nashville, Tennessee, 37203, United States|Research Site, San Antonio, Texas, 78229, United States|Research Site, Fort Belvoir, Virginia, 22060, United States|Research Site, Bedford Park, 5042, Australia|Research Site, Camperdown, 2050, Australia|Research Site, Darlinghurst, 2010, Australia|Research Site, Heidelberg, 3084, Australia|Research Site, Kogarah, 2217, Australia|Research Site, Kurralta Park, 5037, Australia|Research Site, Woolloongabba, 4102, Australia|Research Site, Brussels, 1090, Belgium|Research Site, Brussel, 1200, Belgium|Research Site, Gent, 9000, Belgium|Research Site, Kortrijk, 8500, Belgium|Research Site, Barretos, 14784-400, Brazil|Research Site, Cachoeira De Itapemirim, 29308-055, Brazil|Research Site, Curitiba, 81520-060, Brazil|Research Site, Florianópolis, 88034-000, Brazil|Research Site, Fortaleza, 60810-180, Brazil|Research Site, Lajeado, 95900000, Brazil|Research Site, Porto Alegre, 90619-900, Brazil|Research Site, Rio de Janeiro, 22793-080, Brazil|Research Site, Salvador, 40170-110, Brazil|Research Site, São José do Rio Preto, 15025-100, Brazil|Research Site, São Paulo, 01321-001, Brazil|Research Site, Toronto, Ontario, M5G 2M9, Canada|Research Site, Beijing, 100029, China|Research Site, Beijing, 100142, China|Research Site, Beijing, 100210, China|Research Site, Beijing, 100730, China|Research Site, Changchun, 130012, China|Research Site, Changchun, 130021, China|Research Site, Dalian, 116027, China|Research Site, Guangzhou, 510060, China|Research Site, Guangzhou, 510120, China|Research Site, Guangzhou, 510180, China|Research Site, Hangzhou, 310003, China|Research Site, Hangzhou, 310009, China|Research Site, Hangzhou, 310022, China|Research Site, Kunming, 650118, China|Research Site, Nanjing, 210029, China|Research Site, Nanning, 530021, China|Research Site, Shanghai, 200030, China|Research Site, Shanghai, 200032, China|Research Site, Shanghai, 200072, China|Research Site, Shenyang, 110001, China|Research Site, Suzhou, 215006, China|Research Site, Tianjin, 300050, China|Research Site, Tianjin, 300051, China|Research Site, Tianjin, 300060, China|Research Site, Urumqi, 830000, China|Research Site, Xi'an, 710061, China|Research Site, Xiamen, 361004, China|Research Site, Yangzhou, 225001, China|Research Site, Zhengzhou, 450008, China|Research Site, Ürümqi, 830000, China|Research Site, Bron, 69677, France|Research Site, Lille, 59000, France|Research Site, Limoges Cedex, 87042, France|Research Site, Lyon, 69008, France|Research Site, Paris, 75020, France|Research Site, Aachen, 52074, Germany|Research Site, Berlin, 12351, Germany|Research Site, Berlin, 13125, Germany|Research Site, Berlin, 13359, Germany|Research Site, Coswig, 01640, Germany|Research Site, Gauting, 82131, Germany|Research Site, Gerlingen, 70839, Germany|Research Site, Grosshansdorf, 22927, Germany|Research Site, Halle, 06120, Germany|Research Site, Hamburg, 20251, Germany|Research Site, Homburg, 66421, Germany|Research Site, Immenhausen, 34376, Germany|Research Site, Kassel, 34125, Germany|Research Site, Köln, 51109, Germany|Research Site, Lübeck, 23538, Germany|Research Site, Würzburg, 97074, Germany|Research Site, Hong Kong, 150001, Hong Kong|Research Site, Hong Kong, Hong Kong|Research Site, King's Park, 150001, Hong Kong|Research Site, Budapest, 1083, Hungary|Research Site, Budapest, 1121, Hungary|Research Site, Deszk, 6772, Hungary|Research Site, Székesfehérvár, 8000, Hungary|Research Site, Törökbálint, 2045, Hungary|Research Site, Beer-Sheva, 8410101, Israel|Research Site, Haifa, 31999, Israel|Research Site, Jerusalem, 91120, Israel|Research Site, Kfar-Saba, 4428164, Israel|Research Site, Petah Tikva, 4941492, Israel|Research Site, Ramat Gan, 5262000, Israel|Research Site, Tel Aviv, 6423906, Israel|Research Site, Bari, 70124, Italy|Research Site, Bergamo, 24127, Italy|Research Site, Bologna, 40138, Italy|Research Site, Cremona, 26100, Italy|Research Site, Firenze, 50134, Italy|Research Site, Lucca, 55100, Italy|Research Site, Meldola, 47014, Italy|Research Site, Milano, 20132, Italy|Research Site, Milano, 20141, Italy|Research Site, Milano, 20162, Italy|Research Site, Novara, 28100, Italy|Research Site, Orbassano, 10043, Italy|Research Site, Padova, 35128, Italy|Research Site, Parma, 43126, Italy|Research Site, Roma, 00152, Italy|Research Site, Bunkyo-ku, 113-8431, Japan|Research Site, Fukuoka, 812-8582, Japan|Research Site, Hirakata-shi, 573-1191, Japan|Research Site, Hiroshima-shi, 730-8518, Japan|Research Site, Hiroshima-shi, 734-8551, Japan|Research Site, Kanazawa, 920-8641, Japan|Research Site, Kashiwa, 277-8577, Japan|Research Site, Kitakyushu-shi, 807-8555, Japan|Research Site, Kobe-shi, 650-0047, Japan|Research Site, Kurume-shi, 830-0011, Japan|Research Site, Matsuyama-shi, 791-0280, Japan|Research Site, Nagoya-shi, 453-8511, Japan|Research Site, Niigata-shi, 951-8566, Japan|Research Site, Osakasayama-shi, 589-8511, Japan|Research Site, Sagamihara-shi, 252-0375, Japan|Research Site, Sakai-shi, 591-8555, Japan|Research Site, Sasebo-shi, 857-8511, Japan|Research Site, Sendai-shi, 980-0873, Japan|Research Site, Shinjuku-ku, 160-0023, Japan|Research Site, Sunto-gun, 411-8777, Japan|Research Site, Ube-shi, 755-0241, Japan|Research Site, Yokohama-shi, 240-8555, Japan|Research Site, Yokohama-shi, 241-8515, Japan|Research Site, Yonago-shi, 683-8504, Japan|Research Site, Cheongju-si, 28644, Korea, Republic of|Research Site, Seoul, 02841, Korea, Republic of|Research Site, Seoul, 05030, Korea, Republic of|Research Site, Seoul, 138-736, Korea, Republic of|Research Site, Seoul, 156-707, Korea, Republic of|Research Site, Seoul, 6351, Korea, Republic of|Research Site, Suwon, 16247, Korea, Republic of|Research Site, Suwon, 16499, Korea, Republic of|Research Site, Amsterdam, 1081 HV, Netherlands|Research Site, Arnhem, 6815 AD, Netherlands|Research Site, Hoofddorp, 2134 TM, Netherlands|Research Site, Zwolle, 8025 AB, Netherlands|Research Site, Kraków, 31-202, Poland|Research Site, Otwock, 05-400, Poland|Research Site, Poznan, 60-569, Poland|Research Site, Poznań, 60-569, Poland|Research Site, Racibórz, 47-400, Poland|Research Site, Warszawa, 02-781, Poland|Research Site, Wieliszew, 05-135, Poland|Research Site, Łódź, 90-302, Poland|Research Site, Bucharest, 050098, Romania|Research Site, Bucuresti, 031422, Romania|Research Site, Cluj Napoca, 400015, Romania|Research Site, Craiova, 200385, Romania|Research Site, Focsani, 620165, Romania|Research Site, Iasi, 700483, Romania|Research Site, Timisoara, 300210, Romania|Research Site, Arkhangelsk, 163045, Russian Federation|Research Site, Kazan, 420029, Russian Federation|Research Site, Moscow, 115478, Russian Federation|Research Site, Moscow, 143423, Russian Federation|Research Site, Obninsk, 249036, Russian Federation|Research Site, Omsk, 644013, Russian Federation|Research Site, Pyatigorsk, 357502, Russian Federation|Research Site, Rostov-on-Don, 344037, Russian Federation|Research Site, Ryazan, 390011, Russian Federation|Research Site, Saint Petersburg, 194291, Russian Federation|Research Site, Saint Petersburg, 195271, Russian Federation|Research Site, Saint Petersburg, 198255, Russian Federation|Research Site, Saint-Petersburg, 197758, Russian Federation|Research Site, Sankt-Peterburg, 197758, Russian Federation|Research Site, St. Petersburg, 197022, Russian Federation|Research Site, A Coruña, 15006, Spain|Research Site, Barcelona, 08041, Spain|Research Site, Elche, 03203, Spain|Research Site, Las Palmas de Gran Canaria, 35016, Spain|Research Site, Madrid, 08035, Spain|Research Site, Madrid, 28007, Spain|Research Site, Madrid, 28040, Spain|Research Site, Madrid, 28046, Spain|Research Site, Majadahonda, 28222, Spain|Research Site, Málaga, 29010, Spain|Research Site, San Sebastian, 20014, Spain|Research Site, Valencia, 46010, Spain|Research Site, Valencia, 46026, Spain|Research Site, Zaragoza, 50009, Spain|Research Site, Linköping, 581 85, Sweden|Research Site, Changhua, 50006, Taiwan|Research Site, Putzu City, 0613, Taiwan|Research Site, Taichung City, 402, Taiwan|Research Site, Taichung, 40705, Taiwan|Research Site, Tainan City, 73657, Taiwan|Research Site, Tainan, 70403, Taiwan|Research Site, Taipei, 10002, Taiwan|Research Site, Taipei, 112, Taiwan|Research Site, Tao-Yuan, 333, Taiwan|Research Site, Bangkok, 10330, Thailand|Research Site, Bangkok, 10700, Thailand|Research Site, Chiang Rai, 57000, Thailand|Research Site, Khon Kaen, 40002, Thailand|Research Site, Mueang, 50200, Thailand|Research Site, Phitsanulok, 65000, Thailand|Research Site, Songkla, 90110, Thailand|Research Site, Ankara, 06280, Turkey|Research Site, Ankara, 6500, Turkey|Research Site, Bursa, 16059, Turkey|Research Site, Istanbul, 34069, Turkey|Research Site, Istanbul, 34093, Turkey|Research Site, Istanbul, 34098, Turkey|Research Site, Istanbul, 34722, Turkey|Research Site, Izmir, 35100, Turkey|Research Site, Dnipro, 49102, Ukraine|Research Site, Lviv, 79031, Ukraine|Research Site, Sumy, 40022, Ukraine|Research Site, Uzhhorod, 88000, Ukraine|Research Site, Vinnytsia, 21029, Ukraine|Research Site, Zaporizhzhia, 69040, Ukraine|Research Site, Hanoi, 100000, Vietnam|Research Site, Hanoi, 10000, Vietnam|Research Site, Ho Chi Minh, 70000, Vietnam","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/06/NCT02511106/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/06/NCT02511106/SAP_001.pdf"
